{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T15:10:23Z","timestamp":1700061023200},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T00:00:00Z","timestamp":1145491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 1 immunity appears to be diminished in healthy Japanese carriers of human T\u2010lymphotropic virus type I (HTLV\u2010I), but type 2 status remains undetermined. To further examine the subclinical effect of HTLV\u2010I on host immunity, we measured serum antibodies to the Epstein\u2013Barr virus (EBV) in 415 healthy Japanese adults to broadly characterize type 1 status. Levels of the type 2 biomarkers total immunoglobulin E (IgE), soluble CD23 (sCD23), and soluble CD30 (sCD30) were assessed in 167, 142, and 135 of these subjects, respectively. We analyzed the association of HTLV\u2010I with levels of each serum marker using linear and logistic regression. Altered EBV antibody profiles that are consistent with deficient type 1 immunity were more prevalent in HTLV\u2010I carriers than non\u2010carriers (odds ratio (OR)\u2009=\u20092.8, 95% confidence interval (CI)\u2009=\u20091.5\u20135.3). Carriers also had 45% lower total IgE levels (<jats:italic>P<\/jats:italic>\u2009=\u20090.04) than non\u2010carriers. In contrast, HTLV\u2010I infection was not significantly associated with elevated levels of sCD23 or sCD30. These observations are contrary to our expectation of elevated type 2 biomarkers among carriers. We conclude that in this population, healthy carriers of HTLV\u2010I may have subclinical deficiencies in both type 1 and type 2 immunity, and that type 1 and type 2 immunity are not necessarily reciprocal in persons with subclinical immune dysregulation. J. Med. Virol. 78:847\u2013852, 2006. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.20633","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T15:52:03Z","timestamp":1145548323000},"page":"847-852","source":"Crossref","is-referenced-by-count":6,"title":["Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV\u2010I"],"prefix":"10.1002","volume":"78","author":[{"given":"Brenda M.","family":"Birmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung\u2010Cheng","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Harn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri O.","family":"Stuver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,20]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"285","article-title":"Variations in serum sCD23 in conditions with either enhanced humoral or cell\u2010mediated immunity","volume":"79","author":"Bansal AS","year":"1993","journal-title":"Immunology"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.4731373.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1055-9965.1385.13.8","article-title":"Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults","volume":"13","author":"Birmann B","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_1_5_1","first-page":"1849","volume-title":"Fields virology","author":"Cann AJ","year":"1996"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042560-200105010-00001","article-title":"Cytokine profile and immunomodulation in asymptomatic human T\u2010lymphotropic virus type 1\u2010infected blood donors","volume":"27","author":"Carvalho EM","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.61.5.539"},{"key":"e_1_2_1_8_1","first-page":"426","volume-title":"Leucocyte typing IV","author":"Dallenbach F","year":"1989"},{"key":"e_1_2_1_9_1","first-page":"299","article-title":"Human Th1 and Th2 cells: Functional properties, mechanisms of regulation, and role in disease","volume":"70","author":"Del Prete G","year":"1994","journal-title":"Lab Invest"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60776-2"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.56.71"},{"key":"e_1_2_1_12_1","first-page":"4222","article-title":"Epstein\u2010Barr virus\u2010specific serology in immunologically compromised individuals","volume":"41","author":"Henle W","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(74)80006-7"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199812010-00015"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199911010-00013"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910310210"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01286.x"},{"key":"e_1_2_1_18_1","first-page":"315","article-title":"Epstein\u2010Barr virus\u2010specific immunity in asymptomatic carriers of human T\u2010cell leukemia virus type 1","volume":"70","author":"Kwon K","year":"1995","journal-title":"Hokkaido J Med Sci"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(93)90299-U"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.532"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.1.138"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb03319.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199600001-00002"},{"key":"e_1_2_1_24_1","first-page":"1006","article-title":"Suppression of delayed\u2010type hypersensitivity to PPD and PHA in elderly HTLV\u2010I carriers","volume":"3","author":"Murai K","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.13.1485"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/319282"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450515"},{"key":"e_1_2_1_28_1","first-page":"979","article-title":"Serum soluble CD23 level correlates with subsequent development of AIDS\u2010related non\u2010Hodgkin's lymphoma","volume":"8","author":"Schroeder JR","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease\u2010associated antigen Ki\u20101 in reactive and neoplastic lymphoid tissue: Evidence that the Reed\u2010Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein H","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420605"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240460405"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01546317"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.20633","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.20633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T14:55:38Z","timestamp":1700060138000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.20633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,20]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1002\/jmv.20633"],"URL":"https:\/\/doi.org\/10.1002\/jmv.20633","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,20]]}}}